欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/4011/001
药品名称Benelyte Infusionslösung
活性成分
    • calcium chloride 0.15 mg
    • glucose 11.0 mg
    • magnesium chloride 0.2 mg
    • potassium chloride 0.3 mg
    • sodium 4.08 mg
    • sodium chloride 6.43 mg
剂型Solution for infusion
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Strasse 1 61352 Bad Homburg v.d.H. Germany
参考成员国 - 产品名称Germany (DE)
Elo-Infant Infusionslösung
互认成员国 - 产品名称
    • Estonia (EE)
    • Belgium (BE)
      Kidialyte oplossing voor infusie
    • Netherlands (NL)
    • Luxembourg (LU)
      Benelyte, Solution pour perfusion
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      ELO-MEL paediatric Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Norway (NO)
      Benelyte
    • Finland (FI)
    • Poland (PL)
      Benelyte
    • Hungary (HU)
      BENELYTE oldatos infúzió
    • Czechia (CZ)
      Benelyte
    • Slovakia (SK)
      Benelyte
    • Slovenia (SI)
      Benelyte raztopina za infundiranje
    • Lithuania (LT)
      Benelyte infuzinis tirpalas
    • Latvia (LV)
      Benelyte šķīdums infūzijām
    • Bulgaria (BG)
    • Croatia (HR)
    • Romania (RO)
      Benelyte soluție perfuzabilă
    • Denmark (DK)
      Benelyte
许可日期2016/05/11
最近更新日期2024/02/08
药物ATC编码
    • B05BB02 electrolytes with carbohydrates
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase